ADRM1‐amplified metastasis gene in gastric cancer. Issue 8 (6th June 2015)
- Record Type:
- Journal Article
- Title:
- ADRM1‐amplified metastasis gene in gastric cancer. Issue 8 (6th June 2015)
- Main Title:
- ADRM1‐amplified metastasis gene in gastric cancer
- Authors:
- Fejzo, Marlena S.
Anderson, Lee
Chen, Hsiao‐Wang
Anghel, Adrian
Zhuo, Jiaying
Anchoori, Ravi
Roden, Richard
Slamon, Dennis J. - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The proteasome ubiquitin receptor <italic>ADRM1</italic> has been shown to be a driver for 20q13.3 amplification in epithelial cancers including ovarian and colon cancer. We performed array‐CGH on 16 gastric cancer cell lines and found 20q13.3 to be amplified in 19% with the minimal amplified region in gastric cancer cell line AGS spanning a 1 Mb region including <italic>ADRM1</italic>. Expression microarray analysis shows overexpression of only two genes in the minimal region, <italic>ADRM1</italic> and <italic>OSBPL2</italic>. While RNAi knockdown of both <italic>ADRM1</italic> and <italic>OSBPL2</italic> led to a slight reduction in growth, only <italic>ADRM1</italic> RNAi knockdown led to a significant reduction in migration and growth in soft‐agar. Treatment of AGS cells with the <italic>ADRM1</italic> inhibitor RA190 resulted in proteasome inhibition, but RNAi knockdown of <italic>ADRM1</italic> did not. However, RNAi knockdown of <italic>ADRM1</italic> led to a significant reduction in specific proteins including MNAT1, HRS, and EGFR. We hypothesize that ADRM1 may act in <italic>ADRM1</italic>‐amplified gastric cancer to alter protein levels of specific oncogenes resulting in an increase in metastatic potential. Selective inhibition of ADRM1 independent of proteasome inhibition may result in a targeted therapy for <italic>ADRM1</italic>‐amplified gastric cancer. In vivo models are<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The proteasome ubiquitin receptor <italic>ADRM1</italic> has been shown to be a driver for 20q13.3 amplification in epithelial cancers including ovarian and colon cancer. We performed array‐CGH on 16 gastric cancer cell lines and found 20q13.3 to be amplified in 19% with the minimal amplified region in gastric cancer cell line AGS spanning a 1 Mb region including <italic>ADRM1</italic>. Expression microarray analysis shows overexpression of only two genes in the minimal region, <italic>ADRM1</italic> and <italic>OSBPL2</italic>. While RNAi knockdown of both <italic>ADRM1</italic> and <italic>OSBPL2</italic> led to a slight reduction in growth, only <italic>ADRM1</italic> RNAi knockdown led to a significant reduction in migration and growth in soft‐agar. Treatment of AGS cells with the <italic>ADRM1</italic> inhibitor RA190 resulted in proteasome inhibition, but RNAi knockdown of <italic>ADRM1</italic> did not. However, RNAi knockdown of <italic>ADRM1</italic> led to a significant reduction in specific proteins including MNAT1, HRS, and EGFR. We hypothesize that ADRM1 may act in <italic>ADRM1</italic>‐amplified gastric cancer to alter protein levels of specific oncogenes resulting in an increase in metastatic potential. Selective inhibition of ADRM1 independent of proteasome inhibition may result in a targeted therapy for <italic>ADRM1</italic>‐amplified gastric cancer. In vivo models are now warranted to validate these findings. © 2015 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Genes, chromosomes & cancer. Volume 54:Issue 8(2015:Aug.)
- Journal:
- Genes, chromosomes & cancer
- Issue:
- Volume 54:Issue 8(2015:Aug.)
- Issue Display:
- Volume 54, Issue 8 (2015)
- Year:
- 2015
- Volume:
- 54
- Issue:
- 8
- Issue Sort Value:
- 2015-0054-0008-0000
- Page Start:
- 506
- Page End:
- 515
- Publication Date:
- 2015-06-06
- Subjects:
- Cancer -- Genetic aspects -- Periodicals
616.994042 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2264 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/gcc.22262 ↗
- Languages:
- English
- ISSNs:
- 1045-2257
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4111.763000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3666.xml